RFP
STLN

Root Financial Partners’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Root Financial Partners’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-51
Closed -$157 – 2942
2026
Q1 		$157 Buy
+51
New +$156 ﹤0.01% 3200

Other funds holding STLN

Walleye Capital
Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
KWA
Kingswood Wealth Advisors San Diego, California $2.48B AUM 36.19% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
TC
T3 Companies New York $93.7M AUM
SOW
State of Wyoming Cheyenne, Wyoming $989M AUM 52.24% 1-Year Est. Return
FCG
Fielder Capital Group Nashville, Tennessee $462M AUM 37.71% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Root Financial Partners's STLN Position: Q2 2026 in Review

Root Financial Partners sold out of Starling Oncology Institute, Inc. Common Stock (STLN) in Q2 2026, closing a stake of 51 shares — an estimated $157 sold.

Root Financial Partners first reported a position in STLN in Q1 2026 and held it in 1 quarter. The position peaked at $157 in Q1 2026. 30 funds tracked by Wall St. Rank hold STLN as of Q2 2026.

  • Root Financial Partners reported no remaining Starling Oncology Institute, Inc. Common Stock position as of Q2 2026 after selling out during the quarter.
  • Root Financial Partners sold 51 Starling Oncology Institute, Inc. Common Stock shares in Q2 2026, an estimated $157.
  • Root Financial Partners first reported a position in Starling Oncology Institute, Inc. Common Stock in Q1 2026 and held it in 1 quarter.
  • Root Financial Partners's Starling Oncology Institute, Inc. Common Stock position peaked at $157 in Q1 2026.
  • 30 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.